insights_auto
Why is TWST up 4.05%?
Dive Deeperchevron_right
TWST:NASDAQ
Twist Bioscience Corp
$138.12
arrow_upward
+4.05%(+5.37) 1D
Oct 19, 10:49:34 AM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for TWST...
Open
$136.99
High
$141.80
Low
$133.72
Mkt. cap
9.15B
Avg. vol.
2.81M
Volume
416.95K
52-wk high
$219.71
52-wk low
$23.30
EPS
-$2.22
Beta
2.19
Shares outstanding
65.83M
No. of employees
979
Open
$136.99
High
$141.80
Low
$133.72
Mkt. cap
9.15B
Avg. vol.
2.81M
Volume
416.95K
52-wk high
$219.71
52-wk low
$23.30
EPS
-$2.22
Beta
2.19
Shares outstanding
65.83M
No. of employees
979
News stories
From web sources and news partners
Investing.com Nigeria
·
11 hours ago
Form 144 Twist Bioscience Corp For: 18 October By Investing.com
ad-hoc-news.de
·
1 day ago
TD Cowen raises target to USD 190 for Twist Bioscience stock
Profile
Twist Bioscience is a public biotechnology company based in South San Francisco that manufactures synthetic DNA and DNA products for customers in a wide range of industries. Twist was founded in 2013 by Emily Leproust, Bill Banyai, and Bill Peck.
The company was represented by Leproust at a March 2021 tabletop exercise at the Munich Security Conference simulating an outbreak of weaponized monkeypox.
In May 2021, Twist Bioscience and Genome Project-Write launched a new CAD platform for whole genome design. The CAD will automate workflows to enable collaborative efforts critical for scale-up from designing plasmids to megabases across entire genomes. Wikipedia
About Twist Bioscience Corp